Latest period
$429.50M
YoY change
-11.3%
5Y CAGR
+2.6%
Peak year (2024)
$489.90M
Cumulative CapEx
$6.83B
CapEx history chart for Labcorp Holdings (LH) from 1989 to 2025
Latest: $434.50M
CapEx growth chart for Labcorp Holdings (LH) from 1989 to 2025
Latest: -11.3%
CapEx history table for Labcorp Holdings (LH) from 1989 to 2025
| 2025 | $434.50M | -11.3% | −$55.40M | ||
| 2024 | $489.90M | +8.0% | +$36.30M | ||
| 2023 | $453.60M | -5.9% | −$28.30M | ||
| 2022 | $481.90M | +4.7% | +$21.50M | ||
| 2021 | $460.40M | +20.6% | +$78.70M | ||
| 2020 | $381.70M | -4.6% | −$18.50M | ||
| 2019 | $400.20M | +5.4% | +$20.40M | ||
| 2018 | $379.80M | +20.4% | +$64.40M | ||
| 2017 | $315.40M | +13.1% | +$36.50M | ||
| 2016 | $278.90M | +9.0% | +$23.10M | ||
| 2015 | $255.80M | +25.7% | +$52.30M | ||
| 2014 | $203.50M | +0.6% | +$1.30M | ||
| 2013 | $202.20M | +14.7% | +$25.90M | ||
| 2012 | $176.30M | +21.0% | +$30.60M | ||
| 2011 | $145.70M | +15.2% | +$19.20M | ||
| 2010 | $126.50M | +10.3% | +$11.80M | ||
| 2009 | $114.70M | -26.8% | −$42.00M | ||
| 2008 | $156.70M | +9.4% | +$13.40M | ||
| 2007 | $143.30M | +23.0% | +$26.80M | ||
| 2006 | $116.50M | +24.5% | +$22.90M | ||
| 2005 | $93.60M | -1.5% | −$1.40M | ||
| 2004 | $95.00M | +13.6% | +$11.40M | ||
| 2003 | $83.60M | +12.5% | +$9.30M | ||
| 2002 | $74.30M | -15.7% | −$13.80M | ||
| 2001 | $88.10M | +58.7% | +$32.60M | ||
| 2000 | $55.50M | -20.0% | −$13.90M | ||
| 1999 | $69.40M | -15.8% | −$13.00M | ||
| 1998 | $82.40M | +138.8% | +$47.90M | ||
| 1997 | $34.50M | -36.2% | −$19.60M | ||
| 1996 | $54.10M | -28.2% | −$21.30M | ||
| 1995 | $75.40M | +54.2% | +$26.50M | ||
| 1994 | $48.90M | +45.5% | +$15.30M | ||
| 1993 | $33.60M | -9.7% | −$3.60M | ||
| 1992 | $37.20M | +39.8% | +$10.60M | ||
| 1991 | $26.60M | +78.5% | +$11.70M | ||
| 1990 | $14.90M | -37.1% | −$8.80M | ||
| 1989 | $23.70M | — | — |
- 2025$434.50M-11.3%
- 2024$489.90M+8.0%
- 2023$453.60M-5.9%
- 2022$481.90M+4.7%
- 2021$460.40M+20.6%
- 2020$381.70M-4.6%
- 2019$400.20M+5.4%
- 2018$379.80M+20.4%
- 2017$315.40M+13.1%
- 2016$278.90M+9.0%
- 2015$255.80M+25.7%
- 2014$203.50M+0.6%
- 2013$202.20M+14.7%
- 2012$176.30M+21.0%
- 2011$145.70M+15.2%
- 2010$126.50M+10.3%
- 2009$114.70M-26.8%
- 2008$156.70M+9.4%
- 2007$143.30M+23.0%
- 2006$116.50M+24.5%
- 2005$93.60M-1.5%
- 2004$95.00M+13.6%
- 2003$83.60M+12.5%
- 2002$74.30M-15.7%
- 2001$88.10M+58.7%
- 2000$55.50M-20.0%
- 1999$69.40M-15.8%
- 1998$82.40M+138.8%
- 1997$34.50M-36.2%
- 1996$54.10M-28.2%
- 1995$75.40M+54.2%
- 1994$48.90M+45.5%
- 1993$33.60M-9.7%
- 1992$37.20M+39.8%
- 1991$26.60M+78.5%
- 1990$14.90M-37.1%
- 1989$23.70M—
CapEx values are taken from Labcorp Holdings's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Labcorp Holdings (LH)
According to Labcorp Holdings's latest reported financial statements, the company's current CapEx (TTM) is $429.50M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Labcorp Holdings (LH) CapEx is $434.50M – declined 11.3% year-over-year.
Labcorp Holdings CapEx compound annual growth for the 2020–2025 (5 years) window is +2.6%, with mixed annual results across the window.
Labcorp Holdings CapEx peaked at $489.90M in 2024; the latest annual figure is $434.50M in 2025 (11.3% below peak).
The record annual CapEx stands at $489.90M, reached in 2024; the historical low of $14.90M was recorded in 1990.
Labcorp Holdings Capital Expenditures by Year
Labcorp Holdings Capital Expenditures 2025: $434.50M
In 2025, Labcorp Holdings reported CapEx of $434.50M, declined 11.3% below 2024.
Labcorp Holdings Capital Expenditures 2024: $489.90M
Labcorp Holdings CapEx in 2024 was $489.90M, grew 8.0% from 2023. This figure represents the highest annual value in the available history.
Labcorp Holdings Capital Expenditures 2023: $453.60M
2023's CapEx for Labcorp Holdings came in at $453.60M, declined 5.9% below 2022.
Labcorp Holdings Capital Expenditures 2022: $481.90M
Labcorp Holdings posted CapEx of $481.90M in 2022, edged up 4.7% from 2021.
Labcorp Holdings Capital Expenditures 2021: $460.40M
Labcorp Holdings CapEx in 2021 was $460.40M.
See more financial history for Labcorp Holdings (LH).
Sector peers by CapEx
Healthcare peers of Labcorp Holdings (LH), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Labcorp Holdings (LH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation